About Oncosyne
Oncosyne is a company based in Oslo (Norway) founded in 2020. It operates as a B2B. Oncosyne offers products and services including iCAN R&D, iCAN IVD, and iCAN Tumoroid Platform. Oncosyne operates in a competitive market with competitors including Redbud Medicine, OncoTheis, AlphaVax, Lukas Biomedical and DXOCRO, among others.
- Headquarter Oslo, Norway
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oncosyne
Oncosyne offers a comprehensive portfolio of products and services, including iCAN R&D, iCAN IVD, and iCAN Tumoroid Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Supports pharmaceutical phases from discovery to clinical studies.
Personalizes cancer treatments using patient-derived tumoroids.
Tests drug efficacy and mechanisms for cancer candidates.
Funding Insights of Oncosyne
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Oncosyne
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oncosyne
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncosyne Comparisons
Competitors of Oncosyne
Oncosyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Redbud Medicine, OncoTheis, AlphaVax, Lukas Biomedical and DXOCRO, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Offers comprehensive services in regulatory affairs, R&D, data management, and statistical analysis for healthcare.
|
|
| domain | founded_year | HQ Location |
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and cancer immunotherapy are developed.
|
|
| domain | founded_year | HQ Location |
A biotechnology company developing autologous immune cell therapies to treat various types of cancer.
|
|
| domain | founded_year | HQ Location |
Provides in vitro diagnostic services for oncology research and development.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Oncosyne
When was Oncosyne founded?
Oncosyne was founded in 2020.
Where is Oncosyne located?
Oncosyne is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
What does Oncosyne do?
Oncosyne specializes in advanced tumoroid platforms for precision medicine in healthcare, focusing on colorectal and pancreatic cancers. They provide tools like iCAN RD and iCAN IVD to accelerate pharmaceutical development and personalize treatments for patients. Collaborating with pharma companies and oncologists, they reduce costs and improve outcomes through innovative drug screening. Based in Sweden, they target global healthcare needs.
Who are the top competitors of Oncosyne?
Oncosyne's top competitors include Ontogen, AlphaVax and Cancer Research For Oza Rks.
What products or services does Oncosyne offer?
Oncosyne offers iCAN R&D, iCAN IVD, and iCAN Tumoroid Platform.